SERMION

This brand name is authorized in Austria, Brazil, Hong Kong SAR China, Japan, Lithuania, Mexico, Poland, Romania.

Active ingredients

The drug SERMION contains one active pharmaceutical ingredient (API):

1
UNII JCV8365FWN - NICERGOLINE
 
Read more about Nicergoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C04AE02 Nicergoline C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AE Ergot alkaloids
Discover more medicines within C04AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 552820070070017
HK Department of Health Drug Office 06209, 19045, 33548
JP 医薬品医療機器総合機構 2190021B1095, 2190021F1348
LT Valstybinė vaistų kontrolės tarnyba 1014505, 1014506, 1018881, 1061425
MX Comisión Federal para la Protección contra Riesgos Sanitarios 453M2001
PL Rejestru Produktów Leczniczych 100060789, 100060803
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W67204001, W67204002, W67204003

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈